A groundbreaking study released today shows that a single injectable dose of inactivated polio vaccine (IPV) along with bivalent oral polio vaccine could protect up to 90 percent of children from polio and strengthen community protection against the disease. The research, published in the latest edition of The Lancet, provides the evidence behind the worldwide switch to a new polio vaccine strategy by demonstrating that new schedules of the injectable vaccine with the bivalent oral vaccine protect kids much faster and is safer than using the oral vaccine alone.
↧